hydrogen carbonate has been researched along with Cardiovascular Diseases in 50 studies
Bicarbonates: Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.
hydrogencarbonate : The carbon oxoanion resulting from the removal of a proton from carbonic acid.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Sevelamer hydrochloride also contains chlorine, so a decrease in bicarbonate due to chlorine load was anticipated and metabolic acidosis thought to associate with sevelamer hydrochloride has been reported in some papers." | 4.84 | A review article: sevelamer hydrochloride and metabolic acidosis in dialysis patients. ( Matsuda, H; Miyazaki, M; Oka, Y; Oohara, T; Takatsu, S; Toda, K; Uno, F, 2008) |
| " The aim of this study was to evaluate the effect of a 3-month oral sodium bicarbonate administration on arterial wall stiffness, arterial pressure and serum nutritional markers in non-dialysed patients with chronic kidney disease (CKD) stages 3−5 and metabolic acidosis." | 4.12 | Effects of Oral Bicarbonate Supplementation on the Cardiovascular Risk Factors and Serum Nutritional Markers in Non-Dialysed Chronic Kidney Disease Patients. ( Kurnatowska, I; Nowicka, M; Nowicki, M; Szczecińska, K; Wajdlich, M, 2022) |
| "Metabolic acidosis was one of the earliest complications to be recognized and explained pathologically in patients with CKD." | 2.52 | Current status of bicarbonate in CKD. ( Dobre, M; Hostetter, TH; Rahman, M, 2015) |
| "Hypocitraturia and hypercalciuria are risk factors for calcium stone disease." | 2.47 | Diet-induced metabolic acidosis. ( Adeva, MM; Souto, G, 2011) |
| "Metabolic acidosis is noted in the majority of patients with chronic kidney disease (CKD) when glomerular filtration rate (GFR) decreases to less than 20% to 25% of normal, although as many as 20% of individuals can have acid-base parameters close to or within the normal range." | 2.43 | Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. ( Kraut, JA; Kurtz, I, 2005) |
| "We also modeled predictors of arrhythmias in surgical patients." | 1.91 | Arrhythmias in Critically Ill Surgical and Non-surgical Patients: A National Propensity-Matched Study. ( An, SJ; Charles, A; Davis, D; Gallaher, J; Peiffer, S; Tignanelli, CJ, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (30.00) | 18.7374 |
| 1990's | 3 (6.00) | 18.2507 |
| 2000's | 7 (14.00) | 29.6817 |
| 2010's | 18 (36.00) | 24.3611 |
| 2020's | 7 (14.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szczecińska, K | 1 |
| Wajdlich, M | 1 |
| Nowicka, M | 1 |
| Nowicki, M | 1 |
| Kurnatowska, I | 1 |
| Li, Y | 1 |
| Gao, R | 1 |
| Zhao, B | 1 |
| Zhang, Y | 2 |
| Kendrick, J | 1 |
| You, Z | 1 |
| Andrews, E | 1 |
| Farmer-Bailey, H | 1 |
| Moreau, K | 1 |
| Chonchol, M | 2 |
| Steele, C | 1 |
| Wang, W | 1 |
| Nowak, KL | 1 |
| Patel, N | 1 |
| An, SJ | 1 |
| Davis, D | 1 |
| Peiffer, S | 1 |
| Gallaher, J | 1 |
| Tignanelli, CJ | 1 |
| Charles, A | 1 |
| Al-Kindi, SG | 1 |
| Sarode, A | 1 |
| Zullo, M | 1 |
| Rajagopalan, S | 1 |
| Rahman, M | 4 |
| Hostetter, T | 2 |
| Dobre, M | 4 |
| Wesson, DE | 3 |
| Pajewski, NM | 1 |
| Beddhu, S | 2 |
| Hostetter, TH | 2 |
| Li, P | 1 |
| Servilla, K | 1 |
| Weiner, DE | 1 |
| Wright, JT | 1 |
| Raphael, KL | 2 |
| Căpuşă, C | 1 |
| Ştefan, G | 1 |
| Stancu, S | 1 |
| Lipan, M | 1 |
| Tsur, LD | 1 |
| Mircescu, G | 1 |
| Quiñones, H | 1 |
| Hamdi, T | 1 |
| Sakhaee, K | 1 |
| Pasch, A | 1 |
| Moe, OW | 1 |
| Pak, CYC | 1 |
| Tessitore, N | 1 |
| Santoro, A | 2 |
| Panzetta, GO | 1 |
| Wizemann, V | 1 |
| Perez-Garcia, R | 1 |
| Martinez Ara, J | 1 |
| Perrone, B | 1 |
| Mantovani, W | 1 |
| Poli, A | 1 |
| Yang, W | 1 |
| Chen, J | 1 |
| Drawz, P | 1 |
| Hamm, LL | 1 |
| Horwitz, E | 1 |
| Jaar, B | 1 |
| Lora, CM | 1 |
| Nessel, L | 1 |
| Ojo, A | 1 |
| Scialla, J | 1 |
| Steigerwalt, S | 1 |
| Teal, V | 1 |
| Wolf, M | 1 |
| Kraut, JA | 2 |
| Madias, NE | 2 |
| Park, M | 1 |
| Jung, SJ | 1 |
| Yoon, S | 1 |
| Yun, JM | 1 |
| Yoon, HJ | 1 |
| Rapant, S | 1 |
| Fajčíková, K | 1 |
| Cvečková, V | 1 |
| Ďurža, A | 1 |
| Stehlíková, B | 1 |
| Sedláková, D | 1 |
| Ženišová, Z | 1 |
| Djuric, PS | 1 |
| Jankovic, A | 1 |
| Popovic, J | 1 |
| Tosic Dragovic, J | 1 |
| Bulatovic, A | 1 |
| Djuric, Z | 1 |
| Mitrovic, M | 1 |
| Dimkovic, N | 1 |
| Garg, A | 1 |
| Lavian, J | 1 |
| Lin, G | 1 |
| Sison, C | 1 |
| Oppenheim, M | 1 |
| Koo, B | 1 |
| Oka, Y | 1 |
| Miyazaki, M | 1 |
| Takatsu, S | 1 |
| Oohara, T | 1 |
| Toda, K | 1 |
| Uno, F | 1 |
| Matsuda, H | 1 |
| Segall, L | 1 |
| Mardare, NG | 1 |
| Ungureanu, S | 1 |
| Busuioc, M | 1 |
| Nistor, I | 1 |
| Enache, R | 1 |
| Marian, S | 1 |
| Covic, A | 1 |
| Bolasco, P | 1 |
| Ghezzi, PM | 1 |
| Serra, A | 1 |
| Corazza, L | 1 |
| Fundoni, GF | 1 |
| Pistis, R | 1 |
| Gazzanelli, L | 1 |
| Piras, A | 1 |
| Accalai, G | 1 |
| Calvisi, L | 1 |
| Carpentieri, E | 1 |
| Contu, R | 1 |
| Grussu, S | 1 |
| Mattana, G | 1 |
| Pinna, M | 1 |
| Scalas, MR | 1 |
| Sulis, E | 1 |
| Adeva, MM | 1 |
| Souto, G | 1 |
| Torraca, S | 1 |
| Sirico, ML | 1 |
| Guastaferro, P | 1 |
| Morrone, LF | 1 |
| Nigro, F | 1 |
| Blasio, AD | 1 |
| Romano, P | 1 |
| Russo, D | 1 |
| Bellasi, A | 1 |
| Di Iorio, B | 1 |
| Schroeder, MA | 1 |
| Clarke, K | 1 |
| Neubauer, S | 1 |
| Tyler, DJ | 1 |
| van den Berg, E | 1 |
| Engberink, MF | 1 |
| Brink, EJ | 1 |
| van Baak, MA | 1 |
| Joosten, MM | 1 |
| Gans, RO | 1 |
| Navis, G | 1 |
| Bakker, SJ | 1 |
| Wei, G | 1 |
| Greene, T | 1 |
| Cheung, AK | 1 |
| Barenbrock, M | 1 |
| Schaefer, RM | 1 |
| KOCH, G | 1 |
| Chauveau, P | 1 |
| Nguyen, H | 1 |
| Combe, C | 1 |
| Chêne, G | 1 |
| Azar, R | 1 |
| Cano, N | 1 |
| Canaud, B | 1 |
| Fouque, D | 1 |
| Laville, M | 1 |
| Leverve, X | 1 |
| Roth, H | 1 |
| Aparicio, M | 1 |
| Kurtz, I | 1 |
| Parmley, WW | 1 |
| Hatcher, CR | 1 |
| Ewy, GA | 1 |
| Frommer, PL | 1 |
| Furman, S | 1 |
| Leinbach, RC | 1 |
| Redding, J | 1 |
| Symbas, PN | 1 |
| Weisfeldt, ML | 1 |
| Wasserman, K | 1 |
| Barnatskiĭ, VN | 1 |
| Leoni, V | 1 |
| Zucchelli, P | 1 |
| Spongano, M | 1 |
| Kuno, T | 1 |
| Kikuchi, F | 1 |
| Yanai, M | 1 |
| Nagura, Y | 1 |
| Takahashi, S | 1 |
| O'Neill, PJ | 1 |
| Cobb, LM | 1 |
| Steigman, CK | 1 |
| Chaudry, IH | 1 |
| Kyriazis, J | 1 |
| Stamatiadis, D | 1 |
| Mamouna, A | 1 |
| Love, JN | 1 |
| Howell, JM | 1 |
| Newsome, JT | 1 |
| Skibbie, DF | 1 |
| Dickerson, LW | 1 |
| Henderson, KJ | 1 |
| Schuster, HP | 2 |
| Adrogué, HJ | 1 |
| Rashad, MN | 1 |
| Gorin, AB | 1 |
| Yacoub, J | 1 |
| Von Seggern, K | 1 |
| Egar, M | 1 |
| Fuhrman, BP | 1 |
| Vohra, J | 1 |
| Burrows, GD | 1 |
| Garner, HE | 1 |
| Fodor, JG | 1 |
| Pfeiffer, CJ | 1 |
| Papezik, VS | 1 |
| Jordan, SC | 1 |
| Baum, P | 1 |
| Schölmerich, P | 1 |
| Martinez, LR | 1 |
| Norlander, OP | 1 |
| Kienle, G | 1 |
| Schnitzer, DS | 1 |
| Tregubov, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Systolic Blood Pressure Intervention Trial[NCT01206062] | 9,361 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| Prospective Cohort Study of Chronic Renal Insufficiency[NCT00304148] | 5,499 participants (Anticipated) | Observational | 2003-07-31 | Active, not recruiting | |||
| Alkaline Diet for Insulin Sensitivity[NCT02501343] | 32 participants (Actual) | Interventional | 2015-03-31 | Completed | |||
| Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill : A Multiple Center Randomized Clinical Trial (BICAR-ICU)[NCT02476253] | Phase 3 | 400 participants (Anticipated) | Interventional | 2015-05-05 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01206062)
Timeframe: 6 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Intensive Control of SBP | 10 |
| Standard Control of SBP | 12 |
(NCT01206062)
Timeframe: 6 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Intensive Control of SBP | 155 |
| Standard Control of SBP | 210 |
(NCT01206062)
Timeframe: 6 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Intensive Control of SBP | 243 |
| Standard Control of SBP | 319 |
A 3-step process was used ascertain incident cases of all-cause dementia. First, to identify possible cases of dementia a brief Cognition Screening Battery was administered to all participants. Participants who score below the pre-designated screening cut-point for possible cognitive impairment during follow-up were administered a more comprehensive and detailed neurocognitive test battery (the Extended Cognitive Assessment Battery) plus the Functional Assessment Questionnaire (FAQ) which assesses impairments in daily living skills as a result of cognitive impairments. Last, all the above available tests and questionnaire data were submitted to a centralized, web-based system for adjudication by a panel of dementia experts who assigned final study classifications of probable dementia (PD), mild cognitive impairment (MCI) or no impairment (NI). (NCT01206062)
Timeframe: 6 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Intensive Control of SBP | 149 |
| Standard Control of SBP | 176 |
(NCT01206062)
Timeframe: 6 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Intensive Control of SBP | 12 |
| Standard Control of SBP | 8 |
"Change over 4 years in total white matter lesion volume from baseline Change over 4 years in total brain volume from baseline~Because of the skewed distribution for WML volume, we first applied an inverse hyperbolic sine transformation (asinh), which is similar to a log transformation but can accommodate values of zero. Linear mixed models, including random effects for participant and MRI facility, were used to estimate the change in WML volume and TBV between the treatment groups, including time since randomization (in days) and intracranial volume as covariates. Because the inverse hyperbolic sine transformation is nonlinear, and given the context of a mixed-effects model, back-transformation to the original scale of cm3 is difficult" (NCT01206062)
Timeframe: 4 years
| Intervention | asinh(cm3) (Mean) | |
|---|---|---|
| Change in total white matter lesion volume from ba | Change in total brain volume from baseline | |
| Intensive Control of SBP | 0.23 | -7.7 |
| Standard Control of SBP | 0.37 | -6.8 |
7 reviews available for hydrogen carbonate and Cardiovascular Diseases
| Article | Year |
|---|---|
Current status of bicarbonate in CKD.
Topics: Acidosis; Alkalies; Animals; Bicarbonates; Cardiovascular Diseases; Dietary Supplements; Humans; Ren | 2015 |
A review article: sevelamer hydrochloride and metabolic acidosis in dialysis patients.
Topics: Acidosis; Bicarbonates; Cardiovascular Diseases; Chelating Agents; Chlorine; Clinical Trials as Topi | 2008 |
Diet-induced metabolic acidosis.
Topics: Acid-Base Equilibrium; Acidosis; Bicarbonates; Biomarkers; Cardiovascular Diseases; Citric Acid; Die | 2011 |
Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.
Topics: Animals; Bicarbonates; Carbon Isotopes; Cardiomyopathies; Cardiovascular Diseases; Diagnostic Techni | 2011 |
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
Topics: Acidosis; beta 2-Microglobulin; Bicarbonates; Cardiovascular Diseases; Chronic Disease; Chronic Kidn | 2005 |
Task force V: physical interventions and adjunctive therapy. Emergency cardiac care.
Topics: Airway Obstruction; Assisted Circulation; Bicarbonates; Calcium; Cardiac Pacing, Artificial; Cardiov | 1982 |
Principles of cardiopulmonary medicine.
Topics: Anesthesia, Inhalation; Animals; Bicarbonates; Blood Pressure; Blood Volume; Cardiac Output; Cardiov | 1973 |
10 trials available for hydrogen carbonate and Cardiovascular Diseases
| Article | Year |
|---|---|
Sodium Bicarbonate Treatment and Vascular Function in CKD: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Bicarbonates; Cardiovascular Diseases; Double-Blind Method; Humans; Prospective Studies; Pulse Wave | 2023 |
Serum bicarbonate and cardiovascular events in hypertensive adults: results from the Systolic Blood Pressure Intervention Trial.
Topics: Aged; Bicarbonates; Biomarkers; Cardiovascular Diseases; Female; Humans; Hypertension; Incidence; Ma | 2020 |
Control of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility study.
Topics: Acid-Base Equilibrium; Acidosis; Aged; Bicarbonates; Biomarkers; Calcium Citrate; Cardiovascular Dis | 2019 |
Acetate-free biofiltration reduces intradialytic hypotension: a European multicenter randomized controlled trial.
Topics: Aged; Bicarbonates; Cardiovascular Diseases; Europe; Female; Hemodiafiltration; Hemodialysis Solutio | 2012 |
Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.
Topics: Bicarbonates; Biomarkers; Blood Urea Nitrogen; Body Composition; Body Mass Index; Cardiovascular Dis | 2009 |
Variability of pulse wave velocity and mortality in chronic hemodialysis patients.
Topics: Aged; Aged, 80 and over; Anuria; Bicarbonates; Cardiovascular Diseases; Female; Follow-Up Studies; H | 2011 |
Cardiovascular outcome in critically ill patients treated with continuous haemofiltration--beneficial effects of bicarbonate-buffered replacement fluids.
Topics: Acute Kidney Injury; Bicarbonates; Buffers; Cardiovascular Diseases; Creatinine; Critical Illness; D | 2002 |
Clinical advantages of acetate-free biofiltration.
Topics: Acetates; Acidosis; Adult; beta 2-Microglobulin; Bicarbonates; Blood Urea Nitrogen; Cardiovascular D | 1994 |
Intradialytic and interdialytic effects of treatment with 1.25 and 1. 75 Mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis.
Topics: Aged; Analysis of Variance; Arteries; Bicarbonates; Blood Pressure; Brachial Artery; Calcium; Cardio | 2000 |
[Modification of the THAM effect with low molecular dextran].
Topics: Acid-Base Equilibrium; Bicarbonates; Carbon Dioxide; Cardiovascular Diseases; Dextrans; Edema; Human | 1969 |
33 other studies available for hydrogen carbonate and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of Oral Bicarbonate Supplementation on the Cardiovascular Risk Factors and Serum Nutritional Markers in Non-Dialysed Chronic Kidney Disease Patients.
Topics: Acidosis; Bicarbonates; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; | 2022 |
Low Serum Bicarbonate Levels Increase the Risk of All-Cause, Cardiovascular Disease, and Cancer Mortality in Type 2 Diabetes.
Topics: Adult; Bicarbonates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Neoplasms; Nutritio | 2022 |
Arrhythmias in Critically Ill Surgical and Non-surgical Patients: A National Propensity-Matched Study.
Topics: Albumins; Arrhythmias, Cardiac; Bicarbonates; Cardiovascular Diseases; Critical Illness; Humans; Int | 2023 |
Serum Bicarbonate Concentration and Cause-Specific Mortality: The National Health and Nutrition Examination Survey 1999-2010.
Topics: Aged; Bicarbonates; Cardiovascular Diseases; Cause of Death; Cohort Studies; Correlation of Data; Fe | 2020 |
Serum bicarbonate as a cardiovascular risk factor: evolving from 'non-traditional'?
Topics: Adult; Bicarbonates; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Risk Factors | 2020 |
Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
Topics: Acidosis; Aged; Ankle Brachial Index; Bicarbonates; Biomarkers; Cardiovascular Diseases; Carotid Int | 2017 |
Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Topics: Adult; Aged; Bicarbonates; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Hum | 2013 |
Association of serum bicarbonate with clinical outcomes in CKD: could an increase in serum bicarbonate be a double-edged sword?
Topics: Bicarbonates; Cardiovascular Diseases; Female; Humans; Male; Renal Insufficiency, Chronic | 2013 |
Association between the markers of metabolic acid load and higher all-cause and cardiovascular mortality in a general population with preserved renal function.
Topics: Adult; Bicarbonates; Biomarkers; Cardiovascular Diseases; Female; Humans; Hydrogen-Ion Concentration | 2015 |
Chemical composition of groundwater and relative mortality for cardiovascular diseases in the Slovak Republic.
Topics: Bicarbonates; Calcium; Cardiovascular Diseases; Chlorine; Drinking Water; Groundwater; Humans; Magne | 2015 |
Does an Acid-Milieu in Chronic Kidney Disease Contribute to Its Increased Cardiovascular Mortality?
Topics: Acidosis; Bicarbonates; Cardiovascular Diseases; Chronic Disease; Glomerular Filtration Rate; Humans | 2016 |
Survival Benefit of Hemodiafiltration Compared With Prolonged High-flux Hemodialysis.
Topics: Aged; Anemia; Bicarbonates; Calcium; Cardiovascular Diseases; Cause of Death; Erythropoietin; Female | 2016 |
Does Serum HCO3 Predict Risk for Cardiovascular Disease?
Topics: Bicarbonates; Cardiovascular Diseases; Humans | 2017 |
Clinical characteristics associated with days to discharge among patients admitted with a primary diagnosis of lower limb cellulitis.
Topics: Adult; Aged; Bicarbonates; Cardiovascular Diseases; Cellulitis; Comorbidity; Creatinine; Diabetes Me | 2017 |
Effects of acetate-free haemodiafiltration (HDF) with endogenous reinfusion (HFR) on cardiac troponin levels.
Topics: Acetates; Aged; Bicarbonates; Biomarkers; Blood Pressure; Blood Volume; Buffers; Cardiovascular Dise | 2011 |
Dietary acid load and metabolic acidosis in renal transplant recipients.
Topics: Acidosis; Adult; Aged; Bicarbonates; Cardiovascular Diseases; Cross-Sectional Studies; Diet; Female; | 2012 |
Serum bicarbonate and mortality in adults in NHANES III.
Topics: Adult; Aged; Albuminuria; Bicarbonates; Biomarkers; Body Mass Index; Cardiovascular Diseases; Female | 2013 |
COMPARISON OF CARBON DIOXIDE TENSION, PH AND STANDARD BICARBONATE IN CAPILLARY BLOOD AND IN ARTERIAL BLOOD WITH SPECIAL RESPECT TO RELATIONS IN PATIENTS WITH IMPAIRED CARDIOVASCULAR AND PULMONARY FUNCTION AND DURING EXERCISE.
Topics: Arteries; Bicarbonates; Blood Chemical Analysis; Blood Gas Analysis; Capillaries; Carbon Dioxide; Ca | 1965 |
Dialyzer membrane permeability and survival in hemodialysis patients.
Topics: Aged; Bicarbonates; Body Composition; Body Mass Index; Cardiovascular Diseases; Cause of Death; Chol | 2005 |
The anaerobic threshold measurement to evaluate exercise performance.
Topics: Acidosis; Adult; Anaerobiosis; Bicarbonates; Carbon Dioxide; Cardiovascular Diseases; Exercise Test; | 1984 |
[The potassium deficiency problem].
Topics: Bicarbonates; Body Weight; Cardiovascular Diseases; Female; Humans; Male; Potassium; Potassium Compo | 1984 |
[Elevated water hardness and reduced mortality in cardiovascular disease: history and progress of epidemiologic studies].
Topics: Bicarbonates; Cardiovascular Diseases; Humans; Hydrogen-Ion Concentration; Trace Elements; Water | 1983 |
Acetate-free biofiltration: acidosis correction and cardiovascular stability.
Topics: Acetates; Acidosis; Bicarbonates; Cardiovascular Diseases; Evaluation Studies as Topic; Gastrointest | 1994 |
Prevention of secondary cardiovascular instability after intestinal ischemia and reperfusion improves survival.
Topics: Acidosis; Animals; Bicarbonates; Blood Pressure; Body Water; Cardiovascular Diseases; Fluid Therapy; | 1993 |
The effect of sodium bicarbonate on propranolol-induced cardiovascular toxicity in a canine model.
Topics: Animals; Bicarbonates; Blood Pressure; Cardiovascular Diseases; Disease Models, Animal; Dogs; Electr | 2000 |
[Development and correction of water-electrolyte and acid-base-equilibrium disorders in cardiovascular diseases (proceedings)].
Topics: Acid-Base Imbalance; Bicarbonates; Cardiovascular Diseases; Humans; Prognosis; Water-Electrolyte Imb | 1977 |
Assessing acid-base status in circulatory failure. Differences between arterial and central venous blood.
Topics: Acid-Base Equilibrium; Adult; Aged; Aged, 80 and over; Arteries; Bicarbonates; Cardiovascular Diseas | 1989 |
Cardiopulmonary resuscitation in a pediatric ICU.
Topics: Adolescent; Adult; Bicarbonates; Cardiovascular Diseases; Child; Child, Preschool; Critical Care; Ep | 1986 |
Cardiovascular complications of tricyclic antidepressant overdosage.
Topics: Antidepressive Agents; Arrhythmias, Cardiac; Bicarbonates; Cardiovascular Diseases; Electrocardiogra | 1974 |
Relationship of drinking water quality (hardness-softness) to cardiovascular mortality in Newfoundland.
Topics: Adult; Aged; Bicarbonates; Calcium; Cardiovascular Diseases; Chlorides; Female; Heart; Humans; Hyper | 1973 |
Metabolic acidosis in cyanotic congenital heart disease in infancy.
Topics: Acidosis; Bicarbonates; Carbon Dioxide; Cardiovascular Diseases; Central Nervous System Diseases; Cy | 1969 |
[Intensive therapy and prognosis of acuteheart arrest].
Topics: Acidosis; Adult; Age Factors; Aged; Arrhythmias, Cardiac; Bicarbonates; Blood Circulation; Brain; Ca | 1969 |
Arterial oxygen tensions preceding surgery in patients with cardiovascular or pulmonary disease.
Topics: Adult; Age Factors; Aged; Bicarbonates; Blood Gas Analysis; Cardiovascular Diseases; Female; Humans; | 1968 |